Best Immunotherapy oncologists: TOP 122 doctors

Radiotherapy specialist, Oncologist

Children's Oncologist

Head of the Department of Pediatric Hematology and Oncology.

Professor Bosch is a highly reputed leader in Chronic Lymphocytic Leukemia (CLL) and conducts clinical and basic research on CLL and other lymphoproliferative disorders, focusing on the molecular pathogenesis of CLL and new therapeutic approaches. He has published over 100 articles in prestigious journals and is a professor of haematology at the Vall d'Hebron University Hospital of Barcelona.

Doctor is a Medical Oncologist with expertise in angiogenesis, DNA repair mechanisms, and immunology. She has a degree in medicine from Complutense University of Madrid, a medical oncology MD from the same university, and a PhD from Univesidad Autonoma de Barcelona. She is a Co-Chair of the GEICO Group, Faculty member for the Gyn-Track in the European Society of Medical Oncology, Spanish Representative of GOG, Spanish representative in the Cervical Committee and Phase II Committee of the GCIG Group, and an active member of the American Society of Clinical Oncology, European Society of Medical Oncology, and the Spanish Association of Medical Oncology. She has authored over 100 publications and presentations.

Field of Speciality: Urology
Date of Birth: 1980
School of Medicine:  Istanbul University School of Medicine
Graduate Medical Education: University of Health Sciences Taksim Training & Research Hospital
Fellowship: Urological Oncology and Laparoscopic Urology Department of Urology SLK Kliniken Heilbronn University of Heidelberg, Germany
Foreign Language: English

Having graduated from Istanbul University, Faculty of Medicine in Istanbul, he pursued Urological Surgery residency at University of Health Sciences Taksim Training & Research Hospital, Istanbul from 2005 to 2010. He subsequently completed fellowship training in Urological Oncology and Laparoscopic Urology at Department of Urology, Heilbronn, Heidelberg University, Germany.Dr. Taş is able to provide patients curative surgery that is extremely precise, preserves sexual function, has minimal blood loss, minimal pain and quick recovery.

Firsts of Safe Urology Clinic in Turkey: Penis injections of:
Cellular derived from adipose tissue
mesenchymal Cellular
Male-Shot

​

After graduating from Istanbul Medical Faculty in 2004, Dr. Tuncay Taş completed his specialization in Urology at Taksim Training and Research Hospital in 2010. After the training he received in 2006 and 2007 at the “Laparoscopy, Robotics and Oncology Center” of Heildelberg University, Heilbronn SLK Hospital, Germany, he continues to serve his patients in Turkey, especially in the field of Laparoscopic/Robotic Surgery. The majority of Tuncay Taş’s urology practice consists of man sexual health, cancer diagnosis and treatments

His sexual health and wellness practice offers cutting-edge technologies and treatment options for men. Dr Tas offers unique training and clinical protocols for practitioners who want to implement   Penile Implants , Penile Enhancement , SafeFill and MaleShot  into their practice. Dr Taş and his team presented the results of combined P.R.P (MALE-P-SHOT) and SVF application to the penis for the first time in Turkey at the scientific congress and shared the clinical results of these applications. It is also one of the first 5 centers in the world to publish the results of P.R.P (P.SHOT) applications. Dr Taş is one of the urology instructors at ISSCA who is fully involved in regenerative medicine.

(Source: At the congress organized by İHA International Cellular Therapies Association, Dr. Tuncay Taş shared his cell research in clinical regenerative medicine and erectile dysfunction. 2019, Sexual Medicine-Original Research2021, Apr;9(2):100313.doi:10.1016/j.esxm.2020.100313. Epub 2021 30 January.)

​

Recently Dr. Tas has developed a safe and effective treatment to improve penile circumference and has conducted training with a UK-based certification programme. This novel technique has been shown to have impressive and durable cosmetic results.

​

​

OTHER AREAS OF FOCUS

Robotic prostatectomy, Radical prostatectomy, HoLEP, Donor nephrectomy, Nephrectomy, Robotic surgery, Laparoscopic surgery, Prostate cancer, Kidney cancer, Bladder cancer, Testicular cancer, Retroperitoneal lymph node dissection for testicular cancer, Erectile dysfunction, Sexual dysfunction, Male in, Varicocelectomy, Male hypogonadism, Penile implant insertion, Urethroplasty, Penile reconstruction, Penile enlargement, Urethral reconstruction, Artificial urinary sphincter implantation, Bladder botox injection, Urodynamic testing, Bladder augmentation, Urinary diversion, Urethral stricture, Ureteral obstruction, HIPEC, Reconstructive surgery, Laparoscopic surgery, Fertility preservation, Minimally invasive surgery, Hypospadias

​

Membership of Scientific Organizations

Turkish Association of Urology
Turkish Medical Association
Association of Endourology
European Association of Urology
International Society for Cells Applications

• Publications
https://scholar.google.com/citations?user=CA59D8UAAAAJ&hl=en

​

Prof. Dr. med. Volker Budach *Prof. Dr.med. Volker Budach

He completed his medical studies at the University of Essen and was appointed to the Department of Radiotherapy at the Charité Hospital in Berlin in 1993. He successfully headed this department until 2022, with almost 40 years of professional and 30 years of managerial experience. Under the direction of Prof. Dr. Budach, numerous clinical studies were conducted, especially in the therapy of head and neck tumors. Along with other tumors such as sarcomas, bronchial carcinomas and breast carcinomas, which are his clinical and scientific focus. Prof. Dr. Budach founded and for many years jointly directed the comprehensive cancer center at the Charité. In addition to his function as director of the clinic, he also headed the Charité Center 14, which combined the topics of imaging and oncology. Prof. Budach was President of the German Society for Radiation Oncology (DEGRO) and President of its congress. At the EORTC, he headed the head and neck tumour group for many years. He is the author of numerous important papers on the optimisation of radiotherapy and chemotherapy in the treatment of head and neck tumours. After 30 years of leading the clinic, Prof. Dr. Budach decided to transfer his experience in radiation oncology to the RadioOnkologie Vosspalais clinic. Prof. Dr. Budach is a member of the professional associations DEGRO, ESTRO, ASTRO.

• Specializes in immunotherapy for hematological malignancies.
• Trained in immunology in Germany, extensive international lectures.
• Member of the German Society of Hematology and Medical Oncology.
• Provides remote consultations for immunotherapy second opinions.
• Completed immunology specialization in 1987, senior physician since 2007.

Dr. Raj is a highly experienced Surgical Oncologist with 19 years of experience and over 50,000 cancer surgeries performed. He is involved in numerous clinical trials and has many international and national publications to his credit. He specializes in Breast and Thoracic Surgical Oncology and serves as a professor for DNB Superspecialty Surgical Oncology and Breast Surgery at the Maharashtra University of Health Sciences. His belief is in "adding life to years" and improving the quality of life, not just adding years to life.

Areas of Interest
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Skin Cancer
Stomach Cancer
Liver Cancer
Cervical Cancer
Kidney Cancer
Pancreatic Cancer
Esophageal Cancer

Education
2014 – 2017
Hacettepe University Oncology Institute, Department of Medical Oncology

2009 – 2013
Ufuk University Faculty of Medicine, Department of Internal Medicine

1999 – 2006
Eskişehir Osmangazi University Faculty of Medicine

Work Experience
2024
Neolife Medical Center

2024
Kolan Beylikdüzü Hospital

2023 – 2024
Memorial Bahçelievler Hospital

2020 – 2023
Acıbadem Maslak Hospital

2019 – 2020
İstanbul Aydın University VM Medicalpark Florya Hospital

2017 – 2019
Ministry of Health, Van Education and Research Hospital

2014 – 2017
Hacettepe University Oncology Institute, Medical Oncology Department

2013 – 2014
Kars State Hospital

2009 – 2013
Ufuk University, Dr. Rıdvan Ege Hospital, Department of Internal Medicine

2007 – 2009
Hacettepe University Faculty of Medicine, Department of Physiology

Professional Training
Participation in Turkish Medical Oncology Congresses, National Cancer Congresses, National Immunotherapy and Oncology Congresses
Courses of the Turkish Society of Medical Oncology

Memberships
Turkish Society of Medical Oncology
Istanbul Medical Chamber

Scientific Publications
6 scientific publications in national and international journals
21 abstracts presented at national congresses
3 abstracts presented at international congresses
1 book chapter translation: Atlas of Internal Medicine, 3rd Edition, Chapter 12 – Hepatology, Turkish Translation
3 book chapters:

1. Immunotherapy in Oncology. Immunotherapy in Small Cell Lung Cancer, Chapter 13, 2020
2. Endocrine System Tumors. The Role of Immunotherapy in Neuroendocrine Tumors, Chapter 41, 2021
3. Antineoplastic Drugs. Mechanisms of Action and Classification of Antimetabolites, Chapter 14, 2022
   1 oral presentation at a national congress: Chemotherapy in Cervical Cancer – 3rd National Urogenital Cancer Congress, 2019
   3 abstracts presented at international congresses

Dr. Joan Albanell Mestres is a highly experienced oncologist with an extensive educational and research background. He has completed his MBBS from University Autónoma de Barcelona and has led various research and oncology programs. He has published 120 articles in reputable journals with more than 9000 citations.

Dr. X has a Bachelor of Medicine from Mysore University, India and a Doctor of Medicine in radiotherapy from Banaras Hindu University, India. He is a Diplomate of the National Board of Examination and is a member of the Association of Radiation Oncology of India, Society for Neuro-Oncology, Bangalore Oncology Group, and Indian Association of Hyperthermia Oncology.

Dr. Shruti Kate is a highly trained and experienced oncologist, specializing in the treatment of different types of cancer, including lung, breast, and gynecological cancers. She has done extensive research in the field, and was the sole recipient of a travel award from India in the 2018 World Conference on Lung Cancer.

Dr. Ahmer Arif Shaikh is an MDS with 3 years of experience in Surgical Oncology. He is an expert in oral cancer, organ preservation and functional rehabilitation of oral cancer patients. He is also proficient in performing major maxillofacial and head & neck surgeries, and has a Fellowship training in Head & Neck Surgical Oncology from HCG Manavata Cancer Centre, Nashik. He is also a researcher with many publications under his name.

Dr. Lalit is a highly experienced oncological surgeon with 10 years of experience and over 10,000 major surgeries performed. He has done his MBBS from MIMER, Pune and MS from GMC Panaji. He has fellowship in Surgical Oncology and worked as a Co-principal Investigator in multiple original research. He is known for his patient friendly and ethical approach, and his main interest is in Minimal Invasive Cancer Surgeries.

Medical oncologist, chemotherapist

Prof. Dirk Jager is a Medical Oncologist with 28+ years of experience in Lymphomas, Bone m transplant, Acute Leukemia, Multiple myeloma, Breast Cancer and more. He has received numerous awards, fellowships, and authored many published papers.